How to read: Every bubble is one Indian tamoxifen exporter. X-axis = shipment count; Y-axis = average unit price; bubble size = total revenue. Dashed lines split at the median — exporters in the top-right (Bulk Leaders) combine high volume with premium pricing.
HOW TO READ THIS REPORT
60 seconds
Scan this page — KPIs, thesis, flagship chart, top findings
5 minutes
Read every Key Takeaway line across §1–§9
30 minutes
Read sections tagged for your role ([S] or [B]) end-to-end
In depth
Drill into §10 for your country · supplier / buyer directories at end
02
PART I — OVERVIEW
About This Report
Data sources, methodology, trust signals, and what this Tamoxifen report covers
KEY TAKEAWAYEvery figure in this report is grounded in real commercial tamoxifen trade records. Data comes from official customs filings and public trade sources, runs through a multi-layer quality process, and lands in a clean, consistent report you can rely on.
S FOR SUPPLIERS
Every competitor benchmark, market share figure, and buyer list in this report comes from verified commercial shipments — not surveys or estimates. Use them with confidence when planning your next pitch.
B FOR BUYERS
Every supplier profile, price benchmark, and trade route in this report reflects what that supplier actually ships — real volumes, real destinations, real prices. Use them to qualify and compare Indian tamoxifen suppliers.
§2.1 Reporting parameters · the scope of this 2025-Q4 Tamoxifen India trade report
P
Product scope
Tamoxifen
All variants merged — branded and generic formulations of tamoxifen
T
Time period
2025-Q4
October, November, December 2025 — a single-quarter snapshot
S
Data sources
Official & public trade records
Government customs filings, public trade databases and licensed commercial feeds
G
Geography
India origin → global
Indian sea and air ports shipping to destination markets worldwide
C
Currency
USD (FOB)
Declared Free-on-Board value at the Indian port of loading
R
Shipments analysed
382
Every commercial tamoxifen trade record in the period, aggregated and deduplicated
§2.2 Our quality process · Figure 2.1
Figure 2.1 From raw trade records to a clean report — the four quality pillars.
How to read: Raw trade data (left) flows through four quality checks — source verification, format standardisation, entity matching, and deduplication — to produce the clean, reliable data (right) behind every chart and table in this report.
§2.3 Trust signals · what you can rely on in the numbers you read
DATA COVERAGE
10M+
Pharmaceutical trade records across the full TransData Nexus platform.
COUNTRIES
150+
Origin and destination countries covered in the global pharma trade database.
Platform refresh cadence. This report is a snapshot from the same live data.
§2.4 Limitations · what the data does and does not tell you
WHAT THIS DATA DOES AND DOES NOT SAY
Prices are at the Indian port of loading (FOB), not the final delivered cost in the destination country. Freight, insurance, import duty and local margin are not included.
This is a single-quarter snapshot. Multi-quarter trends, year-over-year growth and historical comparisons are available on the full platform.
A small number of records have incomplete transport mode or destination port fields; these appear blank in the shipment register but are still counted in totals.
This report is a commercial intelligence tool, not a legal audit. For high-stakes decisions, cross-reference with the underlying trade records via the full platform.
03
PART II — MARKET STRUCTURE
Quarterly Trade Overview
Monthly trends, regional performance, and ranking shifts — 2025-Q4
KEY TAKEAWAY2025-Q4 followed a v-curve: Oct $268.2K, Nov $64.6K, Dec $571.1K. Shipment counts rose across the quarter.
S FOR SUPPLIERS
Track which months your competitors were most active, which destinations rose or fell, and whether the Nov dip hit your segment. The bump charts show rank movement — watch for rivals climbing past you.
B FOR BUYERS
Identify whether your current Indian supplier maintained steady shipments through the quarter, or whether they pulled back. Steady suppliers during dips signal reliable partnerships.
1
$268.2K
Oct USD
15 shipments
2
$64.6K
Nov USD
-75.9% MoM
3
$571.1K
Dec USD
+784.3% MoM
4
V-curve
Q4 growth shape
Oct → Nov → Dec
Fig 3.1 Nov dipped 75.9% in USD but shipment count kept climbing.
How to read: Blue bars = monthly USD. Orange line = shipment count. When bars drop but line rises, average shipment value fell. Insight: Oct opened at $268K, making it the middle month by value.
How to read: The curve shows the running total across the quarter. A steeper slope means that month contributed more revenue. Insight: The curve’s steepest section reveals which month drove the most trade value.
How to read: Each coloured layer is one destination region. Layer height = USD in that month. Insight: The top region contributed the most, while the smallest region had the least volume.
How to read: Each line traces a supplier’s monthly rank. Flat = stable position; crossing = rank change. Insight: EUGIA PHARMA SPECIALITIES LTD maintained its leading position.
04
PART II — MARKET STRUCTURE
Global Destination Map
Which countries import tamoxifen from India, how much they buy, and who supplies each market
KEY TAKEAWAYUnited States absorbs 30.5% of India’s 2025-Q4 tamoxifen trade ($276.1K). Beyond the top 10 destinations, 39 countries have fewer than 5 Indian suppliers each — white-space markets where new entrants face minimal competition. Africa has 16 destination countries, the widest regional diversity.
S FOR SUPPLIERS
Use the flow map and lanes table to see which destinations your competitors dominate. For small and mid-size suppliers: look beyond the leading markets — the 39 countries in the long tail have fewer than 5 Indian suppliers each and low competitive barriers.
B FOR BUYERS
Find your country on the map to see how much tamoxifen India ships to your market, who the top suppliers are, and whether you’re in a concentrated or competitive corridor.
Asia
$95K
10.5% of trade
12 countries · 310 shipments
Europe
$260K
28.8% of trade
4 countries · 7 shipments
Americas
$412K
45.6% of trade
7 countries · 14 shipments
Africa
$136K
15.0% of trade
16 countries · 50 shipments
Oceania
$0
0.0% of trade
1 countries · 1 shipments
Fig 4.1 United States is the #1 corridor ($276K) — 30 flow arcs from India radiate across 5 continents.
How to read: The world map shows every country colored by how much Indian tamoxifen it receives (light = low, dark = high). Orange arcs radiate from India to the top 30 destinations; arc thickness = USD value. All destinations are labeled with country name + USD.
§4.1 Top 10 bilateral trade lanes (India → destination) with top Indian suppliers
#
Destination
Total USD
Ships
#1 Indian supplier
USD
#2 Indian supplier
USD
#3 Indian supplier
USD
1
United States
$276K
5
EUGIA PHARMA SPECIALITIES LTD
$276K
—
—
—
—
2
Germany
$247K
3
GRANULES INDIA LTD
$247K
—
—
—
—
3
Mexico
$131K
2
EUGIA PHARMA SPECIALITIES LTD
$131K
ALPHA-PHARMA HEALTHCARE PVT LTD
$135
—
—
4
Madagascar
$116K
11
MEDISKY PHARMACEUTICALS PVT LTD
$116K
—
—
—
—
5
Sri Lanka
$41K
4
KHANDELWAL LABORATORIES PVT LTD
$41K
—
—
—
—
6
Vietnam
$14K
1
BDR PHARMACEUTICALS INTERNATIONAL PVT LTD
$14K
—
—
—
—
7
Lithuania
$13K
2
BIOZENTA LIFESCIENCE PVT LTD
$13K
SPECIALITY MEDICINES LTD
$4
—
—
8
Thailand
$12K
1
BDR PHARMACEUTICALS INTERNATIONAL PVT LTD
$12K
—
—
—
—
9
Iraq
$11K
13
HEET HEALTHCARE PVT LTD
$8K
ZEAL PHARMA
$1K
VATS INDUSTRIES PVT LTD
$1K
10
South Africa
$9K
2
EUGIA PHARMA SPECIALITIES LTD
$9K
COOPER PHARMA LTD
$131
—
—
Table 4.1 — Top 10 destination countries ranked by trade value, with the largest Indian suppliers for each market.
Fig 4.2 Asia leads at 10.5% of USD — but United States is the single largest market.
How to read: Column width = region USD share. Within each column, cells are stacked by country, height = share within region.
§4.2 Destination concentration
30.5%
#1 country share
United States alone
89.8%
Top 5 share
5 of 40 countries
98.9%
Top 15 share
Long tail of 25 countries = 1.1%
HHI 2088
Destination HHI
Moderately concentrated
40
Countries served
Global pharma reach from India
16
Africa countries
Widest regional diversity
Source: TransData Nexus trade data platform
05
PART III — WHO’S IN THIS MARKET
Indian Supplier Rankings & Profiles
63 Indian exporters ranked by value — profiles, portfolios, and competitive intelligence
KEY TAKEAWAYEUGIA PHARMA SPECIALITIES LTD ($415.8K, 46.0% share) and GRANULES INDIA LTD ($247.2K) together control 73.4% of India’s 2025-Q4 tamoxifen trade. The top 5 suppliers hold 93.8%. 63 companies shipped at least once.
S FOR SUPPLIERS
Find your rank, your competitors’ ranks, and the gap in USD/share between you. The profile pages show each top supplier’s buyer portfolio, dosage mix and route map — your competitive-intelligence toolkit.
B FOR BUYERS
Find potential Indian tamoxifen suppliers ranked by size, catalog breadth and destination reach. The profile pages reveal which suppliers have proven trade lanes to your region.
Fig 5.1 EUGIA PHARMA SPECIALITIES LTD leads by $169K over GRANULES INDIA LTD — top 20 Indian exporters ranked by trade value
How to read: Each bar = one Indian supplier ranked by USD. The (#N) shows their rank by shipment count — mismatches reveal pricing strategy. Insight: DERRIC WOOD is #20 by value but #1 by volume.
Fig 5.2 DERRIC WOOD also leads by shipment count (90) but ranking shifts for volume-heavy players
How to read: Same suppliers re-ranked by shipment count. The (#N) shows their rank by USD value. Insight: DERRIC WOOD moves from #1 by volume to #20 by value — fewer but higher-value shipments.
05
PART III — WHO’S IN THIS MARKET
Supply Landscape — Archetypes & Concentration
How India’s 63 tamoxifen suppliers split into strategic segments
KEY TAKEAWAY16 suppliers (25%) generate 99.0% of total trade value. The market splits into four archetypes: Market Leaders, High-Value specialists, Volume players, and a long tail.
Fig 5.3 EUGIA PHARMA SPECIALITIES LTD and GRANULES INDIA LTD sit in the leaders zone — high volume AND high value.
How to read: Each bubble is one Indian supplier. X-axis = shipment count (log scale); Y-axis = total USD value (log scale); bubble size = revenue. Blue dashed lines split at the median. Market Leaders (top-right) combine high volume with high value. Premium Niche (top-left) ship fewer but higher-value consignments. Volume Players (bottom-right) compete on quantity. Long-Tail (bottom-left) are small or occasional exporters. Conclusion: the log scale reveals clear strategic clusters — use this map to identify where your company sits relative to competitors.
Fig 5.4 25% of suppliers = 99.0% of USD — classic concentration.
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 3 destinations and up to 1 importers per destination.
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 2 destinations and up to 2 importers per destination.
06
PART III — WHO’S IN THIS MARKET
Global Buyer Rankings & Intelligence
51 importers across 40 countries — who is buying Indian tamoxifen and how much
KEY TAKEAWAYThe demand side is dramatically more fragmented than supply: the top 25 importers together hold only 82.0% of total USD. 88% of buyers source from a single Indian supplier — a vast pool of lock-in candidates.
S FOR SUPPLIERS
Find the importers buying from your competitors. The rankings reveal who has volume, who pays well, and who sources from multiple Indian suppliers (potential pitch targets).
B FOR BUYERS
See where you rank among global importers of Indian tamoxifen. Compare your USD and shipment count against peers in your country and dosage segment.
Fig 6.1 AUROLOGISTICS LLC is the #1 importer at $276K (30.5%) — top 25 by trade value
How to read: Left semicircle = top 20 Indian suppliers; right = top 20 global buyers. Arc length = total USD; colored ribbons = individual relationships, thickness = USD value. Insight: follow the thickest ribbons to identify the dominant trading pairs.
07
PART IV — MARKET BEHAVIOR
Price Benchmarks & Analysis
How Indian tamoxifen prices vary by supplier, country and dosage form
KEY TAKEAWAYTamoxifen prices span 2887× ($0.0019 → $5.46). The coefficient of variation is 1.70. Dosage form, not destination, is the primary price driver.
S FOR SUPPLIERS
Use the box plot to see where your product sits on the price spectrum. The tornado chart shows exactly where you sit relative to the market median.
B FOR BUYERS
Use this section to benchmark the price you pay against the market. The percentile strip tells you if your current supplier is charging you premium, mid-market or budget rates.
How to read: Each bar shows one supplier’s average unit price relative to the market median (dashed line). Red = above median (premium), green = below (budget).
COMMODITY KINGS
high volume · low unit price
Bulk API/tablet. Largest absolute USD despite lowest per-unit prices. e.g. EUGIA PHARMA SPECIALITIESSourcing: best for cost-driven procurement.
BULK LEADERS
high volume · premium price
Branded-generic leaders, above-median pricing. e.g. KHANDELWAL LABORATORIES PVTSourcing: hardest to displace; compete on relationship.
LONG-TAIL
low volume · low unit price
Spot/opportunistic players. e.g. BDR PHARMACEUTICALS INTERNATIONALSourcing: first to approach for new tenders.
PREMIUM NICHE
low volume · premium price
Sterile injectables and infusions. Hospital-grade. e.g. BIOZENTA LIFESCIENCE PVTSourcing: expect 10× price vs tablet.
07
PART IV — MARKET BEHAVIOR
Price Benchmarks & Analysis
Outlier forensics and the procurement cheat sheet — what to expect to pay by country × dosage
KEY TAKEAWAYExtreme prices are real: the highest are specialty/sterile formulations; the lowest are bulk API. The cheat sheet matrix is the take-home reference for procurement teams.
§7.2 Outlier forensics — top 10 highest and 10 lowest unit prices
↑ TOP 10 HIGHEST USD/UNIT
Date
Exporter
Country
Dosage
Qty
USD
$/unit
Why
Dec 2025
MODI-MUNDIPHARMA…
Nepal
Tablet
180
$3K
$18.40
Specialty / small-batch
Dec 2025
MODI-MUNDIPHARMA…
Nepal
Tablet
20
$368.05
$18.40
Specialty / small-batch
Dec 2025
BRUCK PHARMA PVT…
Burundi
Tablet
10
$59.00
$5.90
Specialty / small-batch
Dec 2025
OCEAN PHARMACEUT…
United Arab Emirates
Capsule
95
$518.67
$5.46
Specialty / small-batch
Oct 2025
HEET HEALTHCARE …
Iraq
Tablet
140
$491.12
$3.51
Specialty / small-batch
Oct 2025
FAMN PHARMA PVT …
China
Tablet
46
$129.09
$2.81
Specialty / small-batch
Oct 2025
FAMN PHARMA PVT …
China
Tablet
1K
$4K
$2.81
Specialty / small-batch
Oct 2025
FAMN PHARMA PVT …
China
Tablet
500
$1K
$2.81
Specialty / small-batch
Oct 2025
FAMN PHARMA PVT …
China
Tablet
54
$151.54
$2.81
Specialty / small-batch
Nov 2025
IASO PHARMACEUTI…
United Arab Emirates
Tablet
51
$141.94
$2.78
Specialty / small-batch
↓ TOP 10 LOWEST USD/UNIT
Date
Exporter
Country
Dosage
Qty
USD
$/unit
Why
Dec 2025
DERRIC WOOD
United Arab Emirates
Tablet
18
$0.030
$0.0017
Bulk generic tablet
Dec 2025
M T MADON EXPORTS
Somalia
Tablet
1K
$1.80
$0.0018
Bulk generic tablet
Dec 2025
DERRIC WOOD
United Arab Emirates
Tablet
33
$0.062
$0.0019
Bulk generic tablet
Dec 2025
DERRIC WOOD
United Arab Emirates
Tablet
33
$0.062
$0.0019
Bulk generic tablet
Dec 2025
DERRIC WOOD
United Arab Emirates
Tablet
63
$0.119
$0.0019
Bulk generic tablet
Dec 2025
MOVID IMPEX
United Arab Emirates
Tablet
10
$0.021
$0.0021
Bulk generic tablet
Dec 2025
MOVID IMPEX
United Arab Emirates
Tablet
8
$0.017
$0.0021
Bulk generic tablet
Dec 2025
AMARI TRADE ALLI…
Turkey
Tablet
500
$1.08
$0.0022
Bulk generic tablet
Dec 2025
FALCON TRANSGLOBAL
United Arab Emirates
Tablet
12
$0.026
$0.0022
Bulk generic tablet
Dec 2025
FALCON TRANSGLOBAL
United Arab Emirates
Tablet
12
$0.026
$0.0022
Bulk generic tablet
§7.3 Procurement cheat sheet — median USD/unit by country × dosage
Fig 7.2 Median unit price by country × dosage form — darker cells = higher prices.
How to read: Each cell shows the median price per unit for that country-dosage combination. Dark blue = expensive, light = cheap. Blank cells = no shipments in that combination.
NEGOTIATION RANGE
Use each cell value as the anchor price. Typical dynamics:
Dosage form is the #1 price driver, not destination
Light cells = easy-entry markets for small suppliers
Dark cells = premium markets requiring regulatory investment
08
PART IV — MARKET BEHAVIOR
Shipping Ports & Trade Routes
Which Indian ports ship tamoxifen, which global ports receive it, and which corridors are high-value vs bulk
KEY TAKEAWAYTamoxifen leaves India through 11+ ports. The top 5 (HYDERABAD ICD, HYDERABAD AIR, AHMEDABAD ICD) handle 97.2% of total USD. ICD moves 5% of shipments.
S FOR SUPPLIERS
Use the dumbbell to classify your port as high-value hub or bulk workhorse. Note the short-sea routes — Bangladesh, Sri Lanka, Myanmar and East Africa are the easiest logistics corridors for first-time exporters.
B FOR BUYERS
Use the destination port ranking to find which Indian ports serve your market. The lead-time estimates tell you what transit time to expect.
Fig 8.1 HYDERABAD ICD handles $407K — top 11 Indian origin ports by trade value.
How to read: Each bar = one destination port worldwide. Bar length = USD value received from India.
§8.1 Reference transit times for key India → global corridors
Route
Mode
Transit time
Notes
NHAVA SHEVA SEA (JNPT) → US East Coast
Sea
22–28 days
Via Suez; 2–3 transshipments typical
NHAVA SHEVA SEA (JNPT) → Lagos (Nigeria)
Sea
18–24 days
Direct liner service available
MUMBAI AIR (SAHAR) → New York JFK
Air
3–5 days
Direct cargo; cold-chain available
MUNDRA SEA → Rotterdam
Sea
20–26 days
Via Suez; Hamburg also served
HYDERABAD AIR → London Heathrow
Air
2–4 days
Pharma-grade cargo corridor
CHENNAI SEA → Chittagong (Bangladesh)
Sea
7–12 days
Short-sea route; high frequency
RAXAUL → Birgunj (Nepal)
Road
1–2 days
Land border crossing
NHAVA SHEVA SEA (JNPT) → Mombasa (Kenya)
Sea
14–20 days
Direct or via Colombo hub
Table 8.1 — Reference times based on standard shipping corridors. Air = 2–5 days; sea = 7–28 days; road = 1–2 days. Add 3–7 days for customs clearance at destination.
08
PART IV — MARKET BEHAVIOR
Shipping Ports & Trade Routes
Trade corridors — origin port to mode of transport to destination region
KEY TAKEAWAYICD dominates at 5% of shipments. The alluvial traces every dollar from Indian origin port through transport mode to destination region.
ICD
$529K
58.5% of USD · 5.5% of ships
AIR
$366K
40.5% of USD · 92.9% of ships
SEA
$5K
0.5% of USD · 1.0% of ships
ROAD
$4K
0.4% of USD · 0.5% of ships
Fig 8.3 The dominant corridor is HYDERABAD ICD → Sea → N. America ($407K).
How to read: Left = Indian origin ports. Middle = transport mode. Right = destination region. Ribbon thickness = USD value; color = mode. Follow the thickest ribbons to find the highest-value corridors.
09
PART V — ACTION
Strategic Opportunities & Action Plan
Market concentration, supply-chain risk, and the dependency patterns that signal where to act
KEY TAKEAWAYMadagascar is the most concentrated destination (HHI 10000, 1 suppliers). Kenya is the most competitive (HHI 3350).
S FOR SUPPLIERS
The HHI barbell shows where competitors have locked up a market (concentrated = poaching opportunity) vs where you must compete on quality (fragmented). The slope chart reveals who is gaining ground.
B FOR BUYERS
The HHI barbell tells you whether your country has enough supplier options. If concentrated (red zone), you have fewer alternatives.
Fig 9.1 Madagascar (HHI 10,000) is the most concentrated — Kenya (HHI 3,350) is the most competitive.
What is HHI? The Herfindahl-Hirschman Index measures how concentrated a market is among its suppliers. It ranges from 0 to 10,000. Below 1,500 (green zone) = many suppliers compete openly — healthy, competitive market with low risk. 1,500–2,500 (yellow zone) = a few suppliers hold significant share — moderate concentration. Above 2,500 (red zone) = one or two suppliers dominate the market — high risk for buyers who may lose supply, and hard to break into for new suppliers. Conclusion: 20 of 20 destination markets are concentrated (red zone). 0 are competitive (green zone). Buyers in red-zone markets should urgently qualify a second Indian supplier to reduce dependency risk.
§9.1 Single-source dependencies
Buyer
Country
Sole supplier
USD
Ships
Risk
AUROLOGISTICS LLC
United States
EUGIA PHARMA SPE…
$276K
5
HIGH
ALIUD PHARMA GMBH
Germany
GRANULES INDIA LTD
$247K
3
HIGH
AUROVIDA FARMACEUTIC…
Mexico
EUGIA PHARMA SPE…
$131K
1
HIGH
PEOPLES BANK
Sri Lanka
KHANDELWAL LABOR…
$21K
2
MEDIUM
VIEMEPR
Vietnam
BDR PHARMACEUTIC…
$14K
1
MEDIUM
PIPHLPT
Thailand
BDR PHARMACEUTIC…
$12K
1
MEDIUM
AUROGEN SOUTH AFRICA…
South Africa
EUGIA PHARMA SPE…
$9K
1
MEDIUM
DALIAN FAIRUS TRADIN…
China
FAMN PHARMA PVT …
$6K
4
MEDIUM
Conclusion: 45 buyers depend on exactly one Indian supplier, representing $736K in trade. For suppliers: each row is a competitor’s locked-in customer you can target.
§9.2 Multi-source resilience
Buyer
Country
Suppliers
USD
Dominant
Resilience
EMIRATES POST GROUP
United Arab Emirates
9
$2K
RUHAN IMPEX
HIGH
EMIRATES POST COMPANY
United Arab Emirates
3
$765
DERRIC WOOD
MEDIUM
Conclusion: 1 of these buyers have HIGH resilience (3+ active suppliers). These are the hardest accounts to win but safest partners for long-term contracts.
09
PART V — ACTION
Strategic Opportunities & Action Plan
Market entry playbook and risk landscape by destination country
KEY TAKEAWAY15 target markets with specific entry approaches. Large suppliers: focus on regulated Tier 1 markets. Small/mid-size: start with Tier 2–3 (low barrier, growing demand).
§9.3 Sourcing recommendations · Table 9.1
Country
Tier
Lead
Price
Risk
Entry approach
United States
Tier 3 (emerging)
14–28 days (sea)
$0.01–$0.10/unit
LOW
First-mover advantage
Germany
Tier 3 (emerging)
3–5 days (air)
$0.01–$0.10/unit
LOW
First-mover advantage
Mexico
Tier 3 (emerging)
3–5 days (air)
$0.01–$0.10/unit
LOW
First-mover advantage
Madagascar
Tier 3 (emerging)
14–28 days (sea)
$0.01–$0.10/unit
LOW
First-mover advantage
Sri Lanka
Tier 3 (emerging)
3–5 days (air)
$1–$10/unit
LOW
First-mover advantage
Vietnam
Tier 3 (emerging)
3–5 days (air)
$0.01–$0.10/unit
LOW
First-mover advantage
Lithuania
Tier 3 (emerging)
3–5 days (air)
$0.10–$1/unit
LOW
First-mover advantage
Thailand
Tier 3 (emerging)
3–5 days (air)
$0.01–$0.10/unit
LOW
First-mover advantage
Iraq
Tier 3 (emerging)
3–5 days (air)
$0.10–$1/unit
LOW
First-mover advantage
South Africa
Tier 3 (emerging)
3–5 days (air)
$0.01–$0.10/unit
LOW
First-mover advantage
China
Tier 3 (emerging)
14–28 days (sea)
$1–$10/unit
LOW
First-mover advantage
Nepal
Tier 3 (emerging)
3–5 days (air)
$1–$10/unit
LOW
First-mover advantage
United Arab Emirates
Tier 2 (competitive)
3–5 days (air)
$0.10–$1/unit
MEDIUM
Price + relationship
Guyana
Tier 3 (emerging)
14–28 days (sea)
$0.10–$1/unit
LOW
First-mover advantage
Nigeria
Tier 3 (emerging)
3–5 days (air)
$0.01–$0.10/unit
LOW
First-mover advantage
For suppliers: Tier 1 markets (US, UK, France) require regulatory investment but offer premium pricing. Tier 3 markets (emerging) have low barriers — ideal for first-time exporters. For buyers: Use the price band and lead time to benchmark your current supplier’s terms.
Fig 9.2 0 markets in the Growth Opportunity zone (competitive + growing). 14 in Fragile Dependency (concentrated + shrinking).
How to read: Each bubble = one destination. X-axis = HHI (concentration). Y-axis = growth %. Bubble size = USD. Green zone (top-left) = Growth Opportunity — competitive markets that are growing, best for new entrants. Red zone (bottom-right) = Fragile Dependency — concentrated + shrinking, high supply-chain risk. Conclusion: Key markets are the top growth opportunities.
09
PART V — ACTION
Action Plan & Easy-Entry Markets
12 prioritised actions + 15 low-competition destination countries for small & mid-size suppliers
KEY TAKEAWAYQuick Wins: execute this quarter. Big Bets: plan for next 6–12 months. Plus 15 countries with ≤5 Indian suppliers — the best entry points for SMEs.
S
FOR SUPPLIERS
ID
Action
Timing
Impact
A1
Pitch top single-source buyer in United States
This Q
HIGH
A2
Offer alternative to EMIRATES POST
This Q
HIGH
A3
Audit Madagascar lock-ins (HHI 10000)
This Q
MED
A5
Enter United States (1 suppliers)
This Q
HIGH
A6
Enter Germany (1 suppliers)
This Q
MED
A8
Build Germany distribution
6–12m
HIGH
A9
Bundle injection/infusion catalog for premium markets
6–12m
MED
B
FOR BUYERS
ID
Action
Timing
Impact
A4
Monitor rising exporters (climbers)
This Q
MED
A7
Register for United States tenders
6–12m
HIGH
A10
Track quarterly HHI shifts across key destinations
This Q
LOW
A11
Map competitor buyer portfolios quarterly
This Q
MED
A12
Qualify second source for single-source buyers
This Q
MED
§9.4 Easy-entry markets — 15 countries with ≤5 Indian suppliers
#
Country
Region
Suppliers
Q4 USD
Growth
Barrier
Why this is easy
1
United States
Other
1
$276K
0%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
2
Germany
Other
1
$247K
-100%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
3
Mexico
Other
2
$131K
0%
LOW
Only 2 Indian suppliers — near-monopoly, easy second-source entry
4
Madagascar
Africa
1
$116K
0%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
5
Sri Lanka
Asia
1
$41K
0%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
6
Iraq
Other
4
$11K
+97.9%
LOW
Growing 98% with only 4 competitors
7
Vietnam
Asia
1
$14K
0%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
8
Lithuania
Other
2
$13K
0%
LOW
Only 2 Indian suppliers — near-monopoly, easy second-source entry
9
Thailand
Asia
1
$12K
0%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
10
South Africa
Africa
2
$9K
-100%
LOW
Only 2 Indian suppliers — near-monopoly, easy second-source entry
11
China
Asia
1
$6K
-100%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
12
Nepal
Asia
2
$5K
0%
LOW
Only 2 Indian suppliers — near-monopoly, easy second-source entry
13
Guyana
Other
1
$4K
-100%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
14
Nigeria
Africa
1
$4K
0%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
15
Cameroon
Africa
5
$3K
0%
LOW
Low competition (5 suppliers), accessible market
This report covers 382 2025-Q4 Tamoxifen shipments.
TransData Nexus tracks 3.37M+ shipments across all pharmaceuticals since 2020.
→ transdatanexus.com/pharmaceutical/tamoxifen
10
PART VI — EVIDENCE REGISTER
Comprehensive Shipment Records by Region
Authoritative source behind all analytics in this report — every shipment appears exactly once
KEY TAKEAWAYThis section contains every one of the 382 2025-Q4 tamoxifen shipments, organised by Region → Exporter → Shipment rows. No row is duplicated.
S FOR SUPPLIERS
Jump to any destination country to see exactly who your competitors ship to, what they charge, through which port, and how often.
B FOR BUYERS
Jump to your country to see every Indian tamoxifen shipment that arrived in 2025-Q4: supplier, price, dosage, port.
§10.1 Global totals
SHIPMENTS
382
across all regions
TOTAL USD
$904K
2025-Q4 FOB value
UNITS
18.9M
tablets, capsules, etc.
SUPPLIERS
63
Indian exporters
BUYERS
51
global importers
COUNTRIES
40
destinations
§10.2 Regional breakdown
Africa
$136K
15.0%
16 ctry · 50 ships
Asia
$95K
10.5%
12 ctry · 310 ships
Europe
$260K
28.8%
4 ctry · 7 ships
Americas
$412K
45.6%
7 ctry · 14 ships
Oceania
$0.0000
0.0%
1 ctry · 1 ships
§10.3 Key insights from the data
🌍
Africa is the largest region at $136K (15.0%), spanning 16 countries.
🏢
63 Indian suppliers shipped to 51 buyers across 40 countries — average shipment value $2K.
📄
Top 0 markets: .
🔍
Every row below is real customs data — date, importer, dosage, brand, quantity, unit price, total USD, origin port, destination port, and transport mode.
All 49 global tamoxifen importers — complete list ranked by USD
KEY TAKEAWAYThis directory lists every company that imported Indian tamoxifen in 2025-Q4.
S FOR SUPPLIERS
Search for potential customers by country and dosage form.
B FOR BUYERS
Find your company and see which Indian supplier serves you.
#
Buyer
Country
Ships
USD
Primary supplier
Dosage forms
1
AUROLOGISTICS LLC
United States
5
$276K
EUGIA PHARMA SPECIAL…
Tablet
2
ALIUD PHARMA GMBH
Germany
3
$247K
GRANULES INDIA LTD
Tablet
3
AUROVIDA FARMACEUTICA SA DE CV
Mexico
1
$131K
EUGIA PHARMA SPECIAL…
Tablet
4
PEOPLES BANK
Sri Lanka
2
$21K
KHANDELWAL LABORATOR…
Tablet
5
VIEMEPR
Vietnam
1
$14K
BDR PHARMACEUTICALS …
Tablet
6
PIPHLPT
Thailand
1
$12K
BDR PHARMACEUTICALS …
Tablet
7
AUROGEN SOUTH AFRICA (PTY) LTD
South Africa
1
$9K
EUGIA PHARMA SPECIAL…
Tablet
8
DALIAN FAIRUS TRADING CO LTD
China
4
$6K
FAMN PHARMA PVT LTD
Tablet
9
ATLAS TRADING COMPANY
Iraq
2
$4K
HEET HEALTHCARE PVT …
Tablet
10
NEW GPC INCQUEENS ATLANTIC INDUSTRI
Guyana
1
$4K
H V A INTERNATIONAL
Tablet
11
SURERISE INVESTMENTS NIGERIA LIMITE
Nigeria
1
$4K
KWALITY PHARMACEUTIC…
Tablet
12
UTL PHARMACY PVT LTD
Nepal
2
$4K
MODI-MUNDIPHARMA PVT…
Tablet
13
EMIRATES POST GROUP
United Arab Emirates
121
$2K
RUHAN IMPEX
Tablet
14
BISTRA PHARMA LINK PVT LTD
Nepal
1
$1K
KHANDELWAL LABORATOR…
Tablet
15
EL BATRAN PHARMACEUTICAL CO.(L.T.D)
South Sudan
1
$1K
ASIAN MEDICAL
Tablet
16
EHSAN COMERCIO GERL LDA
Angola
3
$829.33
ILMIC HEALTH CARE PV…
Tablet
17
EMIRATES POST COMPANY
United Arab Emirates
83
$764.94
DERRIC WOOD
Tablet
18
MARY JAMES ANEI DUT
Sudan
3
$718.77
BAKER & DAVIS PVT LTD
Tablet
19
ANSYNC GLOBAL FZCO
United Arab Emirates
1
$518.67
OCEAN PHARMACEUTICAL
Capsule
20
ASBAR ALMOSTQBAL
Iraq
1
$493.55
RELICURE HEALTHCARE
Tablet
21
WORLD LATAM GATE INC
Panama
1
$471.96
COOPER PHARMA LTD
Tablet
22
RADEEP SERVICES
Singapore
1
$303.38
PHARMA CHOICE LLP
Tablet
23
INDIRA GANDHI MEMOROAL HOSPITAL
Maldives
2
$251.00
NU HOSPITALS PVT LTD
Tablet
24
STEVEN FRANCISCO LEDEZMA NUNEZ
Costa Rica
1
$199.66
SARVODAYA SPECIALTIE…
25
ABU AHMED
Kenya
1
$191.17
AMARI TRADE ALLIANCE…
Tablet
26
S K G THES S ALONIKI CARGO LTD
Greece
1
$185.52
CARECLUB PHARMACEUTI…
Tablet
27
TANGANYIKA HOSPITAL
Burundi
2
$178.59
KHATU ENTERPRISES
Tablet
28
FREIGHTER MADE LOGISTICS LTD
Ghana
1
$169.81
BAKER & DAVIS PVT LTD
Tablet
29
BBG GROUP DOO
Serbia
1
$166.06
BALAJI IMPEX
Tablet
30
CYERDITTRADING CO LTD
Kenya
1
$161.67
AFRO LIFESCIENCE
Tablet
31
TOTAL SHIPPING SA DE CV
Mexico
1
$134.85
ALPHA-PHARMA HEALTHC…
Tablet
32
DEON STEYN
South Africa
1
$131.07
COOPER PHARMA LTD
Tablet
33
CENTRAIMED
Equatorial Guinea
1
$105.64
PIRZE LIFECARE PVT LTD
Tablet
34
LINEHAUL EXPRESS LLC
United Arab Emirates
2
$70.11
RUHAN IMPEX
Tablet
35
STAR CONCORD PTE LTD
Singapore
1
$55.10
ALPHA-PHARMA HEALTHC…
Tablet
36
MR PRO DELIVERY LTD
Mauritius
2
$53.41
TULIP LAB PVT LTD
Tablet
37
AGALLU INTERNACIONAL SA
Panama
1
$48.63
COOPER PHARMA LTD
38
SEA SHELL CARGO
United Arab Emirates
1
$44.25
BALAJI IMPEX
Tablet
39
ZMC EXPRESS CARGO FZCO
United Arab Emirates
8
$42.52
HUMANKIND PHARMA
Tablet
40
CAMEROON ONCOLOGY CENTRE IN DOUALA
Cameroon
2
$30.03
SUDDHASATTWA RAY
Tablet
41
NDZENGUE EBEDE JEAN JOEL
Cameroon
2
$29.69
RUN MEDWAY
Tablet
42
MED-CHIP PHARMACY
Zimbabwe
4
$10.81
S P PHARMA ENTERPRISES
Tablet
43
ZHARAWA LTD
Iraq
1
$5.54
RELICURE HEALTHCARE
Tablet
44
MOHAMED AHEMED MOHAMUD
Somalia
1
$1.80
M T MADON EXPORTS
Tablet
45
ABU ABDU
Turkey
1
$1.08
AMARI TRADE ALLIANCE…
Tablet
46
EMPRESSA 2G
Dominican Republic
1
$0.308
ALPHA-PHARMA HEALTHC…
Tablet
47
DALKHAN MEDICAL SUPPLIES LTD
Saint Lucia
1
$0.229
SARA TRADING CORP
Tablet
48
TRUST ANESTHETIC LTD
Afghanistan
1
$0.0000
VATS INDUSTRIES PVT …
Tablet
49
SESAGO HEALTHCARE LTD
Papua New Guinea
1
$0.0000
ARIHANT EXPORTERS
Tablet
This report covers 382 2025-Q4 Tamoxifen shipments.
TransData Nexus tracks 3.37M+ shipments across all pharmaceuticals since 2020.
→ transdatanexus.com/pharmaceutical/tamoxifen
Talk to our trade analyst
Need a custom tamoxifen report or a deeper dive into any market? Our team is ready.